To determine whether integrin-mediated myeloid support of T-ALL was relevant in a distinct T-ALL mouse model, we carried out comparable experiments in human CD2 promoter-driven LIM domain only 2 (LMO2) transgenic mice43. This evidence concerns the gene LMO2 and acute lymphoblastic leukemia.